Low risk with weak fundamentals.
Revenue
Cost of Revenue
Gross Profit
Other Expenses
Earnings
LIR Life Sciences Corp. operates as biopharmaceutical company that develops transdermal delivery system for obesity and metabolic disorders. The company was incorporated in 2024 and is based in Vancouver, Canada.
No updates